Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Next shop workers win landmark equal pay case

(Sharecast News) - Shop workers at high-street retailer Next won a landmark legal victory on Tuesday, after a six-year battle for equal pay, potentially leading to over £30m in compensation. The employment tribunal's decision would affect 3,540 claimants, predominantly female retail sales staff, who argued they were paid less than their primarily-male counterparts in the warehouse.

According to the Guardian, Next defended the pay discrepancy by citing "market rates" and the need to attract warehouse staff around the clock, including nights, Sundays, and public holidays.

While the tribunal acknowledged the company's cost-cutting motivations and found no direct gender discrimination, it ruled that Next failed to justify the lower pay rates for retail workers.

The tribunal emphasised that financial reasons alone could not excuse unequal pay under the law.

The decision could have far-reaching implications, setting a precedent for similar claims against major UK supermarkets.

Over 112,000 store staff from Asda, Tesco, Sainsbury's, Morrisons, and the Co-op were currently pursuing comparable cases, which could now gain momentum following the Next ruling.

Next, which reported £918m in pre-tax profits for 2023, reportedly planned to appeal the decision.

The ruling mandated the equalisation of hourly pay, back pay compensation, and paid rest breaks for retail staff, aligning their benefits with those of warehouse employees.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

PepsiCo cuts revenue outlook again
(Sharecast News) - PepsiCo cut its annual organic revenue guidance again on Tuesday as it highlighted a "subdued" performance in North America in the third quarter.
Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.